This is a preview of subscription content, log in via an institution to check access.
Reference
de Carvalho TM, et al. Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance. Cancer : 12 Dec 2017. Available from: URL: http://doi.org/10.1002/cncr.31141
Rights and permissions
About this article
Cite this article
Prostate cancer screening 4-yearly at cost effective in USA. PharmacoEcon Outcomes News 794, 25 (2018). https://doi.org/10.1007/s40274-018-4623-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4623-x